Eli Lilly has appointed R/GA as its new social media agency for the weight-loss drug Zepbound and other products like Mounjaro. This follows the FDA's groundbreaking approval of Zepbound for treating sleep apnea, expanding Eli Lilly’s market reach. R/GA will develop social strategies and campaigns while also engaging in experience design for the pharmaceutical company. Meanwhile, R/GA is for sale by Interpublic Group, which is also undergoing a takeover process by Omnicom Group, with a focus on healthcare marketing growth amid rising ad spending projections in the sector.
Eli Lilly has appointed R/GA as its social agency of record to manage social media for its GLP-1 drug, Zepbound, and other brands.
The FDA's approval of Zepbound for sleep apnea marks a significant expansion for Eli Lilly into a new drug market sector.
Collection
[
|
...
]